Ugnė Jonavičė

Ugnė Jonavičė

Auto-generated profile, based on publicly available information

Ugnė Jonavičė

Department of Stem Cell Research, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
KNKarīna Narbute
Karīna Narbute
VPVladimirs Pilipenko
Vladimirs Pilipenko
JPJolanta Pupure
Jolanta Pupure
TKToms Klinovičs
Toms Klinovičs
JAJānis Auders
Jānis Auders
VKVija Klusa
Vija Klusa

29 November 2024 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
JPJustina Pajarskienė
Justina Pajarskienė
AVAgnė Vailionytė
Agnė Vailionytė
IUIeva Uogintė
Ieva Uogintė
Steigvilė ByčenkienėSteigvilė Byčenkienė
Steigvilė Byčenkienė
UJUgnė Jonavičė
Ugnė Jonavičė
RARuta Aldonyte
Ruta Aldonyte

3 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DRDiana Romenskaja
Diana Romenskaja
UJUgnė Jonavičė
Ugnė Jonavičė
APAugustas Pivoriunas
Augustas Pivoriunas
Autophagy dysfunction has been closely related with pathogenesis of many neurodegenerative diseases and therefore represents a potential therapeutic target. Extracellular vesicles (EVs) may act as a potent anti-inflammatory agents and also modulators of autophagy in target cells. However, the molecular mechanisms by which EVs modulate autophagy flux in human microglia remain largely unexplored. In the present study we investigated the effects of EVs derived from human oral mucosa stem cells on the autophagy in human microglia. We demonstrate that EVs promoted autophagy and autophagic flux in human microglia and that this process was dependent on the integrity of lipid rafts. LPS also activated autophagy, but combined treatment with EVs and LPS suppressed autophagy response indicating interference between these signalling pathways. Blockage of Toll-like receptor 4 (TLR4) with anti-TLR4 antibody suppressed EV- induced autophagy. Furthermore, blockage of EV- asscoiated HSP70 chaperone which is one of the endogenous ligands of the TLR4 also suppressed EV- induced lipid raft formation and autophagy. Pre-treatment of microglia with selective inhibitor of αvβ3/αvβ5 integrins cilengitide inhibited EV-induced autophagy. Finally, blockage of purinergic P2X4 receptor (P2X4R) with selective inhibitor 5-BDBD also suppressed of EV-induced autophagy. In conclusion, we demonstrate that EVs activate autophagy in human microglia through interaction with HSP70/TLR4, αVβ3/αVβ5, and P2X4R signalling pathways and that these effects depend on the integrity of lipid rafts. Our findings could be used for development of new therapeutic strategies targeting disease-associated microglia.